Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,292,900 | 1,632,200 | 1,161,500 | 2,961,600 | 1,727,600 |
| Depreciation Amortization | 1,073,600 | 903,200 | 526,300 | 638,000 | 1,117,000 |
| Income taxes - deferred | 361,600 | -158,100 | -305,800 | -168,600 | -426,800 |
| Accounts receivable | 102,700 | 222,300 | 61,300 | -203,400 | 324,800 |
| Other Working Capital | -1,057,600 | -155,200 | -648,700 | -890,300 | -145,500 |
| Other Operating Activity | 431,400 | 431,100 | 752,600 | -953,000 | 1,042,800 |
| Operating Cash Flow | $2,204,600 | $2,875,500 | $1,547,200 | $1,384,300 | $3,639,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -153,800 | -153,700 | -277,000 | 342,300 | -258,100 |
| Net Acquisitions | N/A | -1,074,800 | -6,926,100 | N/A | 28,100 |
| Purchase Of Investment | -1,258,300 | 0 | -5,140,700 | -3,448,500 | -3,808,700 |
| Sale Of Investment | 79,700 | 551,500 | 8,288,500 | 4,661,300 | 3,498,900 |
| Purchase Sale Intangibles | -31,600 | -206,100 | -34,400 | -2,900 | -18,800 |
| Other Investing Activity | -38,700 | -122,200 | -45,700 | 21,500 | -23,900 |
| Investing Cash Flow | $-1,371,100 | $-799,200 | $-4,101,000 | $1,576,600 | $-563,700 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,733,100 | 0 | 997,200 | 0 | 0 |
| Debt Repayment | -1,750,000 | -650,000 | -809,900 | -1,002,200 | -170,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -750,000 | -1,800,000 |
| Other Financing Activity | -285,000 | -33,500 | -38,000 | 4,900 | -116,200 |
| Financing Cash Flow | $-301,900 | $-683,500 | $149,300 | $-1,747,300 | $-2,086,200 |
| Exchange Rate Effect | 101,900 | -67,700 | 35,100 | -55,700 | -59,800 |
| Beginning Cash Position | 2,375,000 | 1,049,900 | 3,419,300 | 2,261,400 | 1,331,200 |
| End Cash Position | 3,008,500 | 2,375,000 | 1,049,900 | 3,419,300 | 2,261,400 |
| Net Cash Flow | $633,500 | $1,325,100 | $-2,369,400 | $1,157,900 | $930,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,204,600 | 2,875,500 | 1,547,200 | 1,384,300 | 3,639,900 |
| Capital Expenditure | -153,800 | -153,700 | -277,000 | -240,300 | -258,100 |
| Free Cash Flow | 2,050,800 | 2,721,800 | 1,270,200 | 1,144,000 | 3,381,800 |